• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • DMF (Drug Master Filing) – Pharmaceutical Products
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • CML (China Manufacture Licence) – Pressure vessels
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • About us
    • Company Profile
    • Partners
    • Testimonials
  • Locations
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Information
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • DMF
      • CCC
      • Pressure Vessels
    • Publications
    • Brochure
    • Online Shop
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • China’s Recent Measures for the Urgent Approval of Medical and Health Products Amid Coronavirus Outbreak

China’s Recent Measures for the Urgent Approval of Medical and Health Products Amid Coronavirus Outbreak

Tuesday, 28 January 2020 / Published in Medical Device

China’s Recent Measures for the Urgent Approval of Medical and Health Products Amid Coronavirus Outbreak

On 23.01.2020, the Ministry of Commerce of the PRC announced (No.3-2020) the list of intermediary services and administrative examinations and approvals for import and export of goods.

The China Chamber of Commerce for Import & Export of Medicines and Health Products continues to be responsible for the import quota monitoring of restricted goods in accordance with regulations of the Public Bidding Measures on Quota of Export Commodities and Detailed Implementation Regulations of Public Bidding on Industry Products Export Quota.

With the aim to promote integrated development of domestic and foreign trade under a well-established management system, this measure supports the reform to delegate power, streamline administration and optimize government services.

On 30.01.2020, the Yunnan Medical Products Administration announced the urgent need to import overseas medical devices to China due to the Coronavirus outbreak, and the NMPA registration process can be omitted if the following requirements are met:

– The medical device meets the US, EU, and Japan standards with a proof of overseas certification and a declaration of product safety and quality

– The medical device is considered necessary by the provincial government in China for the emergency to control the epidemic

As of 05.02.2020, the provincial counterparts of the NMPA had approved the importation even without NMPA approval for 72 categories of medical products, including:

– 2 Medical Masks
– 14 Surgical Masks, 17 Single-use Medical Masks
– 9 Single-use Medical Protective Clothing, 10 Single-use Surgical Clothing
– 2 Reusable Surgical Clothing
– 2 Single-use Medical Caps
– 1 Single-use Surgical Cap
– 1 Medical Isolation Bed
– 1 Isolation Cabin
– 1 Single-use Surgical Napkin Package
– 1 Single-use Sterile Surgical Sheet
– 1 Single-use Medical Examination Glove
– 1 Single-use Surgical Glove
– 1 Noninvasive Ventilator
– 1 Nasal Catheter
– 1 Heating Breathing Pipe
– 1 Infrared Thermometer
– 1 High-flow Humidification Apparatus
– 1 Digital Mobile X-ray Machine
– 1 Single-use Interventional Operation Package
– 1 Single-use Endotracheal Intubation Package
– 1 Single-use Sputum Suction Package

Although the NMPA registration process can be omitted, the new measure aims to strengthen the surveillance of the overseas medical devices before the import certification is issued. During the expedited registration process, the confirmation of approval must be acquired from the Medical Products Administration (MPA) at the provincial level to complete the customs clearance, in order to ensure the product safety and quality of the imported medical devices.

On 07.02.2020, SAMR (CNCA) announced that there are a total of 55 testing and inspection institutions nationally recognized for their testing capabilities on medical devices and personal protective equipment to support the epidemic prevention and control of the latest Coronavirus infection.

The number of institutions are listed with the respective testing capability in the table below:

Number of Testing / Inspection Institutions

Testing Capability

30

Single-use medical protective clothing

(Class II)

34

Surgical Mask

(Class II)

28

Medical Protective Mask

(Class II)

24

Medical Isolation Mask

(Class I)

34

Single-use Medical Rubber Examination Gloves

(Sterile Gloves – Class II)

(Non-sterile Gloves – Class I)

34

Single-use Rubber Sterile Surgical Gloves

(Class II)

In addition, there are another 170 testing and inspection institutions provincially recognized for the testing capabilities of personal protective equipment. Feel free to contact us if you would like to receive more information about the testing and inspection institutions.

On 07.02.2020, the National Medical Products Administration (NMPA) announced (No.71-2020) a list of measures to expedite the approval process of medical protective clothing to prevent the Coronavirus from spreading by:

–           Encouraging the expansion of the production capacity in newly added factory sites

–           Encouraging factories of other product categories to switch to produce medical protective clothing

–           Optimizing the procedures for the registration and production of medical protective clothing

–           Assigning personnel from the relevant government departments to help enterprises meet the requirements sooner

The measures announced on 07.02.2020 are temporary for the current emergency situation and will be lifted after the epidemic is over.

Tagged under: CNCA, coronavirus, Medical Devices, SAMR

What you can read next

Webinar: Medical Devices in China
NMPA Technical Review Guidance Draft for Personalized Implants for Additive Manufacturing
NMPA Annual Report

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Drug Master Filing
      • Health Food
      • Medical Device
    • RoHS
  • Publications
  • Seminars
  • Webinars

Recent Posts

  • Updates on the Medical Device Classification Catalogue in China

    On December 31, 2020, the NMPA announced (No.14...
  • Cisema Partners with Advamed

    Cisema is delighted to announce it is now an as...
  • Guidelines for Sampling Testing on Organic Foods

    On December 4, 2020, the CNCA (Certification an...
  • Draft of Prohibited List and Existing List of Cosmetic Ingredients Announced

    On January 22, 2021, the NIFDC (China National ...
  • Guideline and Standard Update for Medical Devices & IVDs in January and February 2021

    China Regulatory Guidelines Issued / Updated Th...

Archive

Cisema

With nine locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Events
  • News & Information
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2019 Cisema. All rights reserved.

TOP